Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TORRENT PHARMA Share Price    (TORR)

Here is the latest stock price and chart of Torrent Pharma. For more details, see the Torrent Pharma company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report.

Free Guide: Find the Next Crorepati Stock in this Futuristic Industry

REFRESH
Live BSE Quotes Dec 13, 2019 (Close)
Price (Rs)1,865.90 Open (Rs) 1,868.00 High (Rs) 1,872.80 Low (Rs) 1,835.00
% Change0.41 Volume 3,093 Value (Rs) 5,743,822 52-Week H/L 1,964.00 / 1,453.00
Live NSE Quotes Dec 13, 2019 (Close)
Price (Rs)1,865.60 Open (Rs) 1,860.10 High (Rs) 1,874.90 Low (Rs) 1,832.40
% Change0.43 Volume 165,343 Value (Rs) 307,082,430 52-Week H/L 1,962.00 / 1,452.00
Valuation
EPS (Rs)* 32.73 P/E Ratio (x) 57.01 Market Cap (Rs m) 315,822.23 P/BV (x) 6.83
  *Trailing 12 months earnings, excluding extraordinary / exceptional items. BSE Sensex | CNX Nifty

Charts
Loading...
 
Peer Group:
Quote & Graph
     
 S&P BSE SENSEX 
PERIOD
Advanced Charts new
Charts by TradingView

TORRENT PHARMA Share Price Today:

TORRENT PHARMA last traded price was up 0.4% to Rs 1,865.9 on the BSE. On the NSE, TORRENT PHARMA last traded price was up 0.4% to Rs 1,865.6. The total volume of shares traded was 0.2 m.

Overall, the broader S&P BSE HEALTHCARE Index was up by 0.1%. And the benchmark S&P BSE SENSEX was at 41,009.7 (up 1.1%).

Over the last 30 days, the TORRENT PHARMA share price is up 5.3%. And over the last one year, TORRENT PHARMA share price is up 4.4%.





Today's Market

Retail Inflation Data, Air Passenger Traffic in November, and Top Cues in Focus Today(Pre-Open)

On Friday, Indian share markets witnessed positive trading activity throughout the day and ended on a strong note.

Related Views On News

TORRENT PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 36.3% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, TORRENT PHARMA has posted a net profit of Rs 2 bn (up 36.3% YoY). Sales on the other hand came in at Rs 20 bn (up 5.9% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

TORRENT PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 32.5% (Quarterly Result Update)

Jul 25, 2019 | Updated on Jul 25, 2019

For the quarter ended June 2019, TORRENT PHARMA has posted a net profit of Rs 2 bn (up 32.5% YoY). Sales on the other hand came in at Rs 20 bn (up 8.0% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

Use My Secret to Increase Your Trading Profits Today

Dec 10, 2019

What to do after every trade.

How We Made 14.64% Trading Profit in Just 2 Days

Dec 12, 2019

A high probability trade that worked to perfection for my subscribers.

Blue Chips Are Passe. Get into these Stocks for Outstanding Gains in 2020 (Profit Hunter)

Dec 5, 2019

This corner of the market could provide more returns than blue chips in 2020.

Make the Most of the Smallcap Rebound with These Stocks (Profit Hunter)

Dec 3, 2019

Even amid a gloomy economic scenario, there are smallcaps that have grown earnings over last one and a half year and I believe these could be the strongest candidates for a smallcap rebound.

Stocks that Can Outperform No Matter what the RBI Does Today (The 5 Minute Wrapup)

Dec 5, 2019

I won't be surprised if these stocks repeat their 2002-2006 performance.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TRACK TORRENT PHARMA

  • Track your investment in TORRENT PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TORRENT PHARMA

TORRENT PHARMA - ACTAVIS COMPARISON

COMPARE TORRENT PHARMA WITH

MARKET STATS